Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039074
Filing Date
2023-08-07
Accepted
2023-08-07 16:12:08
Documents
115
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnkd-20230630.htm   iXBRL 10-Q 4236907
2 EX-10.1 mnkd-ex10_1.htm EX-10.1 309878
3 EX-10.2 mnkd-ex10_2.htm EX-10.2 130232
4 EX-31.1 mnkd-ex31_1.htm EX-31.1 17751
5 EX-31.2 mnkd-ex31_2.htm EX-31.2 17730
6 EX-32.1 mnkd-ex32_1.htm EX-32.1 12395
7 EX-32.2 mnkd-ex32_2.htm EX-32.2 12386
  Complete submission text file 0000950170-23-039074.txt   18102928

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnkd-20230630_pre.xml EX-101.PRE 674112
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnkd-20230630.xsd EX-101.SCH 114033
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnkd-20230630_lab.xml EX-101.LAB 758763
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnkd-20230630_cal.xml EX-101.CAL 88300
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnkd-20230630_def.xml EX-101.DEF 488300
109 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20230630_htm.xml XML 3809592
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 231147749
SIC: 2834 Pharmaceutical Preparations